Identification of the Anti-bacterial Potential of Drugs on Multidrug-Resistant Bacteria among 1280 FDA-approved Drugs

Presenter

L. Peyclit

Session

Virtual 338 - AAR08 New Antimicrobial Agents (in vitro and in vivo Studies Prior to the Start of Clinical Therapeutic Studies/Pre-phase 2) - New Antimicrobial Structure Activity and Mechanism of Action

Previous ePoster

**Pathologic Features and Genetic Characteristics of Extra-Intestinal Pathogenic Escherichia Coli in Cats and Dogs**

Next ePoster

**Antimicrobial Resistance in Shiga Toxin-producing Strains of Escherichia Coli from the New Territories, Hong Kong**

Identification of the Anti-bacterial Potential of Drugs on Multidrug-Resistant Bacteria among 1280 FDA-approved Drugs

Identification of the Anti-bacterial Potential of Drugs on Multidrug-Resistant Bacteria among 1280 FDA-approved Drugs

Previous ePoster

**Pathologic Features and Genetic Characteristics of Extra-Intestinal Pathogenic Escherichia Coli in Cats and Dogs**

Next ePoster

**Antimicrobial Resistance in Shiga Toxin-producing Strains of Escherichia Coli from the New Territories, Hong Kong**

Iterative Subtractive Binning of Freshwater Chronoseries Metagenomes Identifies over 400 Novel Species and their Ecologic Preferences

Nitrogen Fixation Pigments in Root Nodules of Soybean

**Comparative Genomics and Lipid a Profiling of St307 Klebsiella Pneumoniae Strains from Marseille, France with Various Colistin Susceptibility**

Retrospective Review of Adverse Events and Voluntary Recalls Related to Tattoo and Permanent Makeup Inks in the US

A Huge Leap Forward: Evaluating Bacterial ID Directly from Blood in <15 Hours

Survival of Salinotolerant Bacteria Under the Extreme Chemical and Physical Conditions of Europa and the Icy Ocean Worlds

Arg220 and Diazabicyclooctane (DBO) Inhibitors: Understanding Structure Activity Relationships (SAR) in the PER β-lactamase, a Unique Class A Enzyme

Double Deletion ΔG242-T243 in KPC-14 Dramatically Compromises the Efficacy of Diazabicyclooctane (DBO) Inhibitors

Effectiveness of Antibiotic Neutralization with Broad-spectrum β-lactamase in Whole Blood Patient Samples